One of the most common gynaecological cancers is ovarian cancer (OC). Research on numerous studies is being conducted for new anticancer medications from natural sources, particularly plants, microorganisms, and phytochemicals, as there is an avital need for new therapies with unique mechanisms of action. The search for potent inhibitors is a great way to achieve chemo-protection. By focusing on poly (ADP-ribose) polymerase-1 inhibitors, our in-silico analysis provides screening and discovery of lead compounds. Phytochemicals are a significant source of bioactive molecules with various chemical moieties. This study highlights drug-like qualities, toxicity tests, and in-silico analysis of several phytochemicals in OC using various software. The obtained phytochemicals had the highest docking scores, indicating that they are effective anti-cancer substances for OC. These substances are excellent candidates for further experimental studies because of their bioactive potential and potential drug-like properties.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
